Učitavanje...
Clinical and research priorities for combined modality therapy in stage III NSCLC
Stage III NSCLC comprises of a heterogeneous group of patients with regard to stage, extent of disease and prognosis. Disease presentation can often be complex in clinical practice, and the challenges are not well-defined in clinical trials or practice guidelines. In order to improve the therapeutic...
Spremljeno u:
| Izdano u: | Lung Cancer Manag |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310316/ https://ncbi.nlm.nih.gov/pubmed/30643548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt-2015-0010 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|